Lupin Limited vs Mankind Pharma Limited
A side-by-side comparison of Lupin Limited (LUPIN) and Mankind Pharma Limited (MANKIND) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, Lupin Limited leads LUPIN vs MANKIND on 13 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation40
- Profitability40
- Growth20
- Size & financial health31
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
LUPIN takes 4/4How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
LUPIN takes 4/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
LUPIN takes 2/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
LUPIN takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has delivered good profit growth of 34.3% CAGR over last 5 years", "Company has a good return on equity (ROE) track record: 3 Years ROE 20.8%"]
- − []
- + ["Company has delivered good sales growth of 18.1% CAGR over last 5 years"]
- − ["Stock is trading at 5.77 times its book value"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.